Literature DB >> 15768012

Study of the venous reflux progression.

Nicos Labropoulos1, Luis Leon, Sung Kwon, Apostolos Tassiopoulos, José A Gonzalez-Fajardo, Steven S Kang, M Ashraf Mansour, Fred N Littooy.   

Abstract

BACKGROUND: Patients with chronic venous disease (CVD) often ask whether elective vein surgery could be delayed without consequences. Because the natural history of CVD is not well known, this study was designed to determine its progression in such patients.
METHODS: One hundred and sixteen limbs in 90 patients who had at least 2 exams with duplex ultrasound (DU) scanning prior to vein surgery at a university medical center were studied. These were patients who were offered an operation but for various reasons were treated at a later stage. Patients were classified by the CEAP system.
RESULTS: The mean age of the patients was 49 years (range, 23 to 81 years). A second DU scan was performed 1 to 43 months after the initial exam (median, 19 months). Eighty-five limbs (73.3%) were unchanged. Thirteen limbs (11.2%) had progression of clinical stage, and seven had progression on DU scanning as well. Seven limbs progressed from C2 to C3, four limbs from C3 to C4, and two limbs from C4 to C6. Thirty-four limbs had a documented change on repeat DU scanning. In 3 of these limbs, reflux was missed on the initial exam; therefore, 31 limbs had progression of disease. The great saphenous vein and tributaries were the most often anatomic sites affected by a change, followed by perforators. Seventeen limbs (14.7%) had extension of pre-existing reflux, and 14 (12.1%) had reflux in a new segment. In 11 of these limbs, a change in the initial plan for treatment was required. Symptomatic or DU changes were noted 6 months or later in 95% of limbs and 74.2% of limbs with disease progression were diagnosed at 12 months or later. All but one of the 13 symptomatic limbs developed symptoms at least a year later.
CONCLUSION: Nearly one third of patients with venous reflux had progression. Anatomic extension is frequent with disease progression but not a pre-requisite. Progression was found in most limbs 6 months after the initial study. Patients undergoing treatment for their veins may need another DU exam if this time interval is exceeded.

Entities:  

Mesh:

Year:  2005        PMID: 15768012     DOI: 10.1016/j.jvs.2004.11.014

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  14 in total

1.  The endovenous ASVAL method: principles and preliminary results.

Authors:  Mehmet Mahir Atasoy; Levent Oğuzkurt
Journal:  Diagn Interv Radiol       Date:  2016 Jan-Feb       Impact factor: 2.630

2.  Carboxytherapy: Controls the inflammation and enhances the production of fibronectin on wound healing under venous insufficiency.

Authors:  Themis M M Brochado; Laynna de Carvalho Schweich; Naudimar Di Pietro Simões; Rodrigo J Oliveira; Andréia C M B Antoniolli-Silva
Journal:  Int Wound J       Date:  2018-11-22       Impact factor: 3.315

3.  Classification of reflux patterns in patients with great saphenous vein insufficiency and correlation with clinical severity.

Authors:  Sezen Yılmaz; Burçak Çakır Peköz; Neris Dincer; Sinan Deniz; Levent Oğuzkurt
Journal:  Diagn Interv Radiol       Date:  2021-03       Impact factor: 2.630

Review 4.  CHIVA method for the treatment of chronic venous insufficiency.

Authors:  Sergi Bellmunt-Montoya; Jose Maria Escribano; Jaume Dilme; Maria José Martinez-Zapata
Journal:  Cochrane Database Syst Rev       Date:  2015-06-29

5.  Treatment Patterns and Outcomes in Patients with Varicose Veins.

Authors:  Rajiv Mallick; Aditya Raju; Chelsey Campbell; Rashad Carlton; David Wright; Kimberly Boswell; Michael Eaddy
Journal:  Am Health Drug Benefits       Date:  2016-11

Review 6.  Interventions for great saphenous vein incompetence.

Authors:  Jade Whing; Sandip Nandhra; Craig Nesbitt; Gerard Stansby
Journal:  Cochrane Database Syst Rev       Date:  2021-08-11

Review 7.  CHIVA method for the treatment of chronic venous insufficiency.

Authors:  Sergi Bellmunt-Montoya; Jose Maria Escribano; Percy Efrain Pantoja Bustillos; Cristina Tello-Díaz; Maria José Martinez-Zapata
Journal:  Cochrane Database Syst Rev       Date:  2021-09-30

Review 8.  S2k guidelines: diagnosis and treatment of varicose veins.

Authors:  F Pannier; T Noppeney; J Alm; F X Breu; G Bruning; I Flessenkämper; H Gerlach; K Hartmann; B Kahle; H Kluess; E Mendoza; D Mühlberger; A Mumme; H Nüllen; K Rass; S Reich-Schupke; D Stenger; M Stücker; C G Schmedt; T Schwarz; J Tesmann; J Teßarek; S Werth; E Valesky
Journal:  Hautarzt       Date:  2022-04-19       Impact factor: 1.198

9.  Forkhead box C2 promoter variant c.-512C>T is associated with increased susceptibility to chronic venous diseases.

Authors:  Sumi Surendran; Athira Girijamma; Radhakrishnan Nair; Kalpana S Ramegowda; Divya H Nair; Jissa V Thulaseedharan; Ravikumar B Lakkappa; Giridhar Kamalapurkar; Chandrasekharan C Kartha
Journal:  PLoS One       Date:  2014-03-07       Impact factor: 3.240

Review 10.  Superficial venous insufficiency from the infernal to the endothermal.

Authors:  D Carradice
Journal:  Ann R Coll Surg Engl       Date:  2014-01       Impact factor: 1.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.